246 related articles for article (PubMed ID: 32520761)
1. Recurrent Loss of SMARCA4 in Sinonasal Teratocarcinosarcoma.
Rooper LM; Uddin N; Gagan J; Brosens LAA; Magliocca KR; Edgar MA; Thompson LDR; Agaimy A; Bishop JA
Am J Surg Pathol; 2020 Oct; 44(10):1331-1339. PubMed ID: 32520761
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Molecular Profiling of Sinonasal Teratocarcinosarcoma Highlights Recurrent SMARCA4 Inactivation and CTNNB1 Mutations.
Rooper LM; Agaimy A; Gagan J; Simpson RHW; Thompson LDR; Trzcinska AM; Ud Din N; Bishop JA
Am J Surg Pathol; 2023 Feb; 47(2):224-233. PubMed ID: 36206446
[TBL] [Abstract][Full Text] [Related]
3. Fine needle aspiration cytology of metastatic SMARCA4-deficient sinonasal teratocarcinosarcoma: First report in literature.
Gopakumar A; Kakkar A; Kaur K; Sikka K; Thakar A; Sharma A; Jain D
Diagn Cytopathol; 2023 Apr; 51(4):E129-E136. PubMed ID: 36680532
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract][Full Text] [Related]
5. SMARCA4/BRG1-Deficient Sinonasal Carcinoma.
Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing reveals activating CTNNB1 mutations in SMARCA4/BRG1-deficient sinonasal carcinomas: a report of two new cases and a brief review of the literature with an emphasis on histogenesis.
Zhao M; Ma T; He X; Ge M
Virchows Arch; 2023 Feb; 482(2):453-460. PubMed ID: 36396744
[TBL] [Abstract][Full Text] [Related]
7. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract][Full Text] [Related]
8. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
Agaimy A
Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
[TBL] [Abstract][Full Text] [Related]
9. SMARCA4-deficient Sinonasal Carcinoma.
Agaimy A; Weichert W
Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic algorithm for challenging blue cell sinonasal carcinoma.
Laforga JB; Abdullah B
Pathol Res Pract; 2023 Aug; 248():154683. PubMed ID: 37478521
[TBL] [Abstract][Full Text] [Related]
11. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1
Agaimy A; Fuchs F; Moskalev EA; Sirbu H; Hartmann A; Haller F
Virchows Arch; 2017 Nov; 471(5):599-609. PubMed ID: 28555282
[TBL] [Abstract][Full Text] [Related]
12. SWI/SNF-deficient head and neck neoplasms: An overview.
Agaimy A; Bishop JA
Semin Diagn Pathol; 2021 May; 38(3):175-182. PubMed ID: 33663878
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
14. SALL-4 and Beta-Catenin Expression in Sinonasal Teratocarcinosarcoma.
Compton ML; Lewis JS; Faquin WC; Cipriani NA; Shi Q; Ely KA
Head Neck Pathol; 2022 Mar; 16(1):229-235. PubMed ID: 34106411
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
[TBL] [Abstract][Full Text] [Related]
16. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
[TBL] [Abstract][Full Text] [Related]
17. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
Bookhout C; Bouldin TW; Ellison DW
Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
[TBL] [Abstract][Full Text] [Related]
18. Sinonasal teratocarcinosarcoma: a clinicopathologic and immunohistochemical study of 6 cases.
Fatima SS; Minhas K; Din NU; Fatima S; Ahmed A; Ahmad Z
Ann Diagn Pathol; 2013 Aug; 17(4):313-8. PubMed ID: 23462185
[TBL] [Abstract][Full Text] [Related]
19. SWI/SNF-deficient Sinonasal Carcinomas.
Agaimy A
Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
[TBL] [Abstract][Full Text] [Related]
20. A unique uterine cervical "teratocarcinosarcoma": a case report.
Ito K; Yano M; Ogasawara A; Miwa M; Kozawa E; Yasuda M
Diagn Pathol; 2019 Nov; 14(1):122. PubMed ID: 31684979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
